Kimelman & Baird, LLC Abb Vie Inc. Transaction History

Kimelman & Baird, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 19, 2024	SELL	$154.79 - $180.76 $4.53 Million - $5.29 Million	-29,289 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$105.21 - $117.21 $28,932 - $32,232	275 Added 0.95%	29,289 $3.3 Million
Q3 2019 Dec 10, 2019	SELL	$62.98 - $75.72 $1,259 - $1,514	-20 Reduced 0.07%	29,014 $2.2 Million
Q2 2019 Nov 22, 2019	BUY	$65.7 - $83.98 $1.91 Million - $2.44 Million	29,034 New	29,034 $2.11 Million

3,849

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Kimelman & Baird, LLC, based on Form 13F filings with the SEC.

Stay updated on Kimelman & Baird, LLC with notifications on news.